Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Not Confirmed
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Not Confirmed
Not Confirmed
18-19 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Industry Trade Show
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Industry Trade Show
Not Confirmed
18-19 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
29 Oct 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/innovent-awaiting-chinese-regulators-verdict-posts-another-psoriasis-win
28 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-announces-results-of-a-phase-2-study-of-picankibart-anti-il-23p19-antibody-in-plaque-psoriasis-showing-efficacy-in-patients-with-prior-inadequate-response-to-il-17-biologics-302289289.html
16 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-announces-phase-2-clinical-study-of-picankibart-ibi112-in-chinese-patients-with-ulcerative-colitis-met-primary-endpoint-302277657.html
07 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-and-ask-pharm-announce-strategic-collaboration-for-limertinib-a-third-generation-egfr-tki-for-the-treatment-of-lung-cancer-302268648.html
26 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-announces-nmpa-acceptance-of-nda-for-picankibart-anti-il-23p19-antibody-for-treating-moderate-to-severe-plaque-psoriasis-302259367.html
18 Sep 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/esmo-innovent-links-cytokine-fusion-protein-responses-colorectal-cancer
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?